| Name | Title | Contact Details |
|---|
Xena Health is a Hartford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mobile Medical Corporation is a Bethel Park, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Palo Alto Research Center is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthStream (NASDAQ: HSTM) is dedicated to improving patient outcomes through the development of healthcare organizations` greatest asset: their people. Our solutions are used by healthcare organizations to meet their regulatory training requirements, increase patient resuscitation rates, improved their patients’ experiences of care, train their employees on the new ICD-10 coding system, manage the credentialing process of their workforce, expedite employees’ onboarding processes, streamline competency & performance management, and to meet many other requirements, goals, and objectives. With our corporate office based in Nashville, TN, HealthStream has additional offices in Laurel, MD, Brentwood, TN, Pensacola, FL, Jericho, NY, San Diego, CA, and Nashville, TN (Highland Ridge Office).)
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.